PERCEPTIVE ADVISORS LLC
Top Portfolio Positions
90 positions ·
$5,116,451,791 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
2,035,986 | $655,974,329 | 12.82% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,127,200 | $356,938,608 | 6.98% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
1,531,421 | $350,281,925 | 6.85% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
8,285,461 | $229,507,269 | 4.49% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
5,258,903 | $208,883,627 | 4.08% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
2,373,795 | $206,448,951 | 4.04% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
3,783,225 | $190,825,869 | 3.73% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
1,580,505 | $161,922,737 | 3.16% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
4,423,974 | $139,355,181 | 2.72% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
1,230,879 | $129,734,646 | 2.54% |
Portfolio Trend
25 quarters · across all stocks
Holdings in INBX
Shares Held
Position Value (USD)
8 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96,993,191 | 1,442,707 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $114,763,853 | 1,452,707 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $44,717,171 | 1,327,707 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,954,518 | 977,892 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,885,723 | 1,064,026 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $16,386,000 | 1,064,026 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,662,647 | 1,064,026 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,077,248 | 1,064,026 | Shares | Sole | 2024-08-16 | |
| No 13F history on record for this holder in this stock. | ||||||